Up to $200,000/yr direct costs for up to 3 years ($600,000 total)

LOI: March 1
Application: March 15

The Leukemia & Lymphoma Society's (LLS) Translational Research Program (TRP)  was established to encourage and provide support for new and novel clinical research. The goal of the program is to accelerate transfer of findings from the laboratory to clinical application. The program's purpose is to fund research that shows high promise for translating basic biomedical knowledge to prevention or new treatments and, ultimately, to prolong and enhance life.

Eligibility criteria:

• Principal Investigator must hold an MD, PhD, or equivalent
• Applications may involve multiple institutions and the Applicant (Principal Investigator) should have an independent research or academic position
• Applicant (Principal Investigator) need not be U.S. citizen

Click Here.